Harvey Partners LLC 13D/13G Filings for Harvard Bioscience, Inc. (HBIO)

Harvey Partners LLC 13D and 13G filings for Harvard Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
4:05 pm
Sale		 2023-12-31 13G Harvard Bioscience, Inc.
HBIO		 Harvey Partners LLC 2,557,500
6.000%		 -354,000decrease
(-12.16%)		 Filing
2023-02-14
4:05 pm
Purchase		 2022-12-31 13G Harvard Bioscience, Inc.
HBIO		 Harvey Partners LLC 2,911,500
7.000%		 2,911,500increase
(New Position)		 Filing